Healios K.K. (OTCMKTS:HLOSF – Get Free Report)’s share price fell 0.8% during trading on Wednesday . The company traded as low as 1.21 and last traded at 1.21. 900 shares traded hands during trading, a decline of 23% from the average session volume of 1,176 shares. The stock had previously closed at 1.22.
Healios K.K. Stock Performance
The business has a 50 day moving average of 1.02 and a 200 day moving average of 1.10.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
See Also
- Five stocks we like better than Healios K.K.
- 3 Best Fintech Stocks for a Portfolio Boost
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- Consumer Discretionary Stocks Explained
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Most Volatile Stocks, What Investors Need to Know
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
